Silvia Hernández-Llodrà

ResearcherID ORCID

Publication Activity (10 Years)

Years Active: 2019-2023
Publications (10 Years): 5

Top Topics

Prostate Cancer

Cell Proliferation

Top Venues

Virchows Archiv : an international journal of pathology

This page only lists publications with an associated author ORCID identifier.

Publications

Laura Segalés, Nuria Juanpere-Rodero, Nerea Gallarín, Marta Lorenzo, David López, Júlia Perera-Bel, Alejo Rodriguez-Vida, Lluis Fumadó, Lluís Cecchini, Joaquim Bellmunt, Josep Lloreta-Trull, Silvia Hernández-Llodrà
Immunohistochemical markers as predictors of prognosis in multifocal prostate cancer. Virchows Archiv : an international journal of pathology (2023)
Silvia Hernández-Llodrà, Laura Segalés, Nuria Juanpere-Rodero, Tech Marta Lorenzo, Marta Salido, Lara Nonell, Tech David López, Alejo Rodríguez-Vida, Joaquim Bellmunt, Lluís Fumadó, Lluís Cecchini, Josep Lloreta-Trull
SPOP and CHD1 alterations in prostate cancer: Relationship with PTEN loss, tumor grade, perineural infiltration, and PSA recurrence. The Prostate 81 (16) (2021)
Laura Segalés, Nuria Juanpere, Marta Lorenzo, Raquel Albero-González, Lluís Fumadó, Lluís Cecchini, Joaquim Bellmunt, Josep Lloreta-Trull, Silvia Hernández-Llodrà
Strong cytoplasmic ETV1 expression has a negative impact on prostate cancer outcome. Virchows Archiv : an international journal of pathology 475 (4) (2019)
Raquel Albero-González, Silvia Hernández-Llodrà, Nuria Juanpere, Marta Lorenzo, Adrià Lloret, Laura Segalés, Xavier Duran, Lluís Fumadó, Lluís Cecchini, Josep Lloreta-Trull
Immunohistochemical expression of mismatch repair proteins (MSH2, MSH6, MLH1, and PMS2) in prostate cancer: correlation with grade groups (WHO 2016) and ERG and PTEN status. Virchows Archiv : an international journal of pathology 475 (2) (2019)
Silvia Hernández-Llodrà, Laura Segalés, Ainara Safont, Nuria Juanpere, Marta Lorenzo, Lluís Fumadó, Alejo Rodríguez-Vida, Lluís Cecchini, Joaquim Bellmunt, Josep Lloreta-Trull
SPOP and FOXA1 mutations are associated with PSA recurrence in ERG wt tumors, and SPOP downregulation with ERG-rearranged prostate cancer. The Prostate 79 (10) (2019)